Department of Clinical Laboratory, Shengzhou People's Hospital, Shengzhou Branch of the First Affiliated Hospital of Zhejiang University, Shengzhou, China.
J Clin Lab Anal. 2021 Apr;35(4):e23730. doi: 10.1002/jcla.23730. Epub 2021 Feb 20.
To explore the value of neutrophil count to albumin ratio (NAR) in predicting the outcomes of patients with HBV-associated decompensated cirrhosis (HBV-DeCi).
One hundred and fifty-four HBV-DeCi patients were enrolled. The 30-day mortality was determined. Multivariate analysis was applied to identify risk factors for poor outcomes. Receiver operating characteristic curve analyses was performed to evaluate prognostic accuracy.
The 30-day mortality was 10.4%. NAR was significantly higher in non-survivors than in survivors and was an independent predictor for unfavorable prognosis.
The present results indicate that increased NAR is associated with poor survival in HBV-DeCi patients and has potential for clinical application.
探讨中性粒细胞与白蛋白比值（NAR）预测乙型肝炎相关失代偿性肝硬化（HBV-DeCi）患者结局的价值。
纳入 154 例 HBV-DeCi 患者，确定 30 天死亡率。采用多因素分析确定不良结局的危险因素。进行受试者工作特征曲线分析评估预后准确性。
30 天死亡率为 10.4%。非幸存者的 NAR 显著高于幸存者，是不良预后的独立预测因子。
本研究结果表明，HBV-DeCi 患者 NAR 升高与生存不良相关，具有临床应用潜力。
